NPPB and hydrops fetalis: The serial testing of NT-proBNP levels should be included in the post-discharge indications for follow-ups due to its potential usefulness in titrating the therapy for HF [210,211]; the optimal monitoring interval needs to be tailored to the underlying risk in the patient [212].